InspireMD, Inc.
NSPR- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001433607
In the last 90 days, InspireMD, Inc. insiders filed 5 open-market purchases and 0 sales; 38 institutions reported holding it in 13F filings for Q3 2026, worth $14.6M in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 18, 2026
- $37.1M
- Insider buysLast 90 days, $455.0K in total
- 5
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ3 2026, +2 vs. previous quarter
- 38
- 13F valueReported value at the end of Q3 2026
- $14.6M
- Superinvestors holdingAt the end of Q3 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $8.98M
- +28.1% year over year
- Net income, FY2025
- -$48.8M
- No comparable prior period
- Free cash flow, FY2025
- -$36.8M
- No comparable prior period
- Revenue, Q3 FY2026
- $2.24M
- −11.1% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Net loss for FY2025: $48.8M (543.3% of revenue).
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 251.5K
- Shares sold short
- Change
- +170.6K
- +210.9% vs. previous
- Days to cover
- 1.00
- At average daily volume
Superinvestors holding NSPR, Q3 2026
Go to the superinvestors tabNo superinvestor reported holding NSPR at the end of Q3 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by InspireMD, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2026 (view filing)4:05 PM ET | Nov 13 | 4 days | Stuka PaulDirector | PPurchase | +307.7K | $0.65 | +$200.0K | +72.6%731.4K after | |
| Nov 17, 2026 (view filing)4:05 PM ET | Nov 13 | 4 days | Stuka PaulDirector | PPurchase | +230.8K | $0.00 | $0 | –230.8K after | Derivative |
| Nov 17, 2026 (view filing)4:05 PM ET | Nov 13 | 4 days | Lawless Michael AChief Financial Officer | PPurchase | +115.4K | $0.65 | +$75.0K | +16.7%807.1K after | |
| Nov 17, 2026 (view filing)4:05 PM ET | Nov 13 | 4 days | Lawless Michael AChief Financial Officer | PPurchase | +86.5K | $0.00 | $0 | –86.5K after | Derivative |
| Nov 17, 2026 (view filing)4:05 PM ET | Nov 13 | 4 days | Berman MichaelDirector | PPurchase | +76.9K | $0.65 | +$50.0K | +21.8%429.5K after | |
| Nov 17, 2026 (view filing)4:05 PM ET | Nov 13 | 4 days | Berman MichaelDirector | PPurchase | +57.7K | $0.00 | $0 | –57.7K after | Derivative |
| Nov 17, 2026 (view filing)4:05 PM ET | Nov 13 | 4 days | Slosman MarvinCEO and President | PPurchase | +46.2K | $0.65 | +$30.0K | +1.3%3.60M after | |
| Nov 17, 2026 (view filing)4:05 PM ET | Nov 13 | 4 days | Slosman MarvinCEO and President | PPurchase | +34.6K | $0.00 | $0 | –34.6K after | Derivative |
| Nov 17, 2026 (view filing)4:05 PM ET | Nov 13 | 4 days | Roubin Gary SDirector | PPurchase | +153.8K | $0.65 | +$100.0K | +18.4%988.3K after | |
| Nov 17, 2026 (view filing)4:05 PM ET | Nov 13 | 4 days | Roubin Gary SDirector | PPurchase | +115.4K | $0.00 | $0 | –115.4K after | Derivative |
Top 10 13F holders, Q3 2026
See all 38 holdersThe largest institutional positions in InspireMD, Inc. at the end of Q3 2026; share changes are against Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Rosalind Advisors, Inc. | 3,905,743 | $2.62M | 0.85% | 00.0% | Unchanged |
| Standard Life Aberdeen plc | 3,698,364 | $2.48M | 0.00% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 3,376,484 | $2.25M | 0.13% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 3,133,405 | $2.09M | 0.04% | 00.0% | Unchanged |
| Parkman Healthcare Partners LLC | 2,416,518 | $1.61M | 0.15% | 00.0% | Unchanged |
| Marshall Wace, LLP | 1,860,405 | $1.25M | 0.00% | 00.0% | Unchanged |
| Soleus Capital Management, L.P. | 1,045,708 | $698.3K | 0.02% | 00.0% | Unchanged |
| Velan Capital Investment Management LP | 924,680 | $617.5K | 0.59% | +776,542+524.2% | Added |
| Ingalls & Snyder LLC | 362,550 | $242.0K | 0.01% | −6,250−1.7% | Reduced |
| Affiance Financial, LLC | 250,370 | $167.2K | 0.02% | 00.0% | Unchanged |
Holders of 5% or more of NSPR
See all 9 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of InspireMD, Inc..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Marshall Wace, LLP | 13G/A | 9.99%28.1M shares | – | Nov 14, 20251 filing | Nov 14, 2025 | SEC |
| Nantahala Capital Management, LLC | 13G/A | 9.99%4.82M shares | 0.00 ppfrom 9.99% | Feb 14, 20246 filings | May 15, 2026 | SEC |
| Rosalind Advisors, Inc. | 13G/A | 9.20%11.0M shares | −0.70 ppfrom 9.90% | Jun 8, 202312 filings | Feb 11, 2026 | SEC |
| Lawless Michael A | 13D | 8.60%3.61M shares | New | Oct 29, 20251 filing | Oct 29, 2025 | SEC |
| Standard Life Aberdeen plc | 13G/A | 7.49%3.17M shares | +1.54 ppfrom 5.95% | Nov 7, 20252 filings | Feb 2, 2026 | SEC |